{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T05:37:47Z","timestamp":1758346667239,"version":"3.44.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T00:00:00Z","timestamp":1742342400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T00:00:00Z","timestamp":1742342400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s00210-025-04000-6","type":"journal-article","created":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T05:41:19Z","timestamp":1742362879000},"page":"12167-12178","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical outcomes with all-oral regimens in patients of drug-resistant tuberculosis: A prospective study in a tertiary hospital in North India"],"prefix":"10.1007","volume":"398","author":[{"given":"Vijay","family":"Kumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G S","family":"Sri Bharathi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohit","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sankha Shubhra","family":"Chakrabarti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Upinder","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jai Krishn","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,19]]},"reference":[{"key":"4000_CR1","doi-asserted-by":"publisher","first-page":"A113","DOI":"10.1016\/j.chest.2016.02.118","volume":"149","author":"H Arshad","year":"2016","unstructured":"Arshad H, Cheema T (2016) Killing two nerves with one drug: the ethambutol way. Chest 149:A113","journal-title":"Chest"},{"key":"4000_CR2","doi-asserted-by":"publisher","first-page":"1901522","DOI":"10.1183\/13993003.01522-2019","volume":"54","author":"S Borisov","year":"2019","unstructured":"Borisov S, Danila E, Maryandyshev A, Dalcolmo M, Miliauskas S, Kuksa L et al (2019) Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report. Eur Respir J 54:1901522","journal-title":"Eur Respir J"},{"key":"4000_CR3","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1056\/NEJMoa2119430","volume":"387","author":"F Conradie","year":"2022","unstructured":"Conradie F, Bagdasaryan TR, Borisov S, Howell P, Mikiashvili L, Ngubane N et al (2022) Bedaquiline\u2013pretomanid\u2013linezolid regimens for drug-resistant tuberculosis. New England J Med 387:810\u2013823","journal-title":"New England J Med"},{"key":"4000_CR4","doi-asserted-by":"crossref","unstructured":"Korotych O, Achar J, Gurbanova E, Hovhannesyan A, Lomtadze N, Ciobanu A et al (2024) Effectiveness and safety of modified fully oral 9-month treatment regimens for rifampicin-resistant tuberculosis: a prospective cohort study. Lancet Infect Dis 24:1151\u20131161","DOI":"10.1016\/S1473-3099(24)00228-7"},{"key":"4000_CR5","unstructured":"Ministry of Health and Family Welfare. NTEP (2021) Guidelines for Programmatic management of drug resistant tuberculosis in India. https:\/\/tbcindia.mohfw.gov.in\/wp-content\/uploads\/2023\/05\/8368587497Guidelines-for-PMDT-in-India-1.pdf. Accessed Feb\u00a013 2025"},{"key":"4000_CR6","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1378\/chest.77.1.98","volume":"77","author":"VS Nair","year":"1980","unstructured":"Nair VS, LeBrun M, Kass I (1980) Peripheral neuropathy associated with ethambutol. Chest 77:98\u2013100","journal-title":"Chest"},{"key":"4000_CR7","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1016\/S1473-3099(21)00811-2","volume":"22","author":"N Ndjeka","year":"2022","unstructured":"Ndjeka N, Campbell JR, Meintjes G, Maartens G, Schaaf HS, Hughes J et al (2022) Treatment outcomes 24 months after initiating short, all-oral bedaquiline-containing or injectable-containing rifampicin-resistant tuberculosis treatment regimens in South Africa: a retrospective cohort study. Lancet Infect Dis 22:1042\u20131051","journal-title":"Lancet Infect Dis"},{"key":"4000_CR8","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.ijid.2022.11.007","volume":"126","author":"TMP Nguyen","year":"2023","unstructured":"Nguyen TMP, Le THM, Merle CSC, Pedrazzoli D, Nguyen NL, Decroo T et al (2023) Effectiveness and safety of bedaquiline-based, modified all-oral 9\u201311-month treatment regimen for rifampicin-resistant tuberculosis in Vietnam. Int J Infect Dis 126:148\u2013154","journal-title":"Int J Infect Dis"},{"key":"4000_CR9","doi-asserted-by":"publisher","first-page":"e938","DOI":"10.1093\/cid\/ciac528","volume":"76","author":"C Padmapriyadarsini","year":"2022","unstructured":"Padmapriyadarsini C, Vohra V, Bhatnagar A, Solanki R, Sridhar R, Anande L et al (2022) Bedaquiline, delamanid, linezolid, and clofazimine for treatment of pre-extensively drug-resistant tuberculosis. Clin Infect Dis 76:e938\u2013e946","journal-title":"Clin Infect Dis"},{"key":"4000_CR10","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/S2213-2600(18)30235-2","volume":"6","author":"K Schnippel","year":"2018","unstructured":"Schnippel K, Ndjeka N, Maartens G, Meintjes G, Master I, Ismail N et al (2018) Effect of bedaquiline on mortality in South African patients with drug-resistant tuberculosis: a retrospective cohort study. Lancet Respir Med 6:699\u2013706","journal-title":"Lancet Respir Med"},{"key":"4000_CR11","doi-asserted-by":"publisher","first-page":"100405","DOI":"10.1016\/j.jctube.2023.100405","volume":"34","author":"O Ur Rehman","year":"2024","unstructured":"Ur Rehman O, Fatima E, Ali A, Akram U, Nashwan A, Yunus F (2024) Efficacy and safety of bedaquiline containing regimens in patients of drug-resistant tuberculosis: An updated systematic review and meta-analysis. J Clin Tuberc Other Mycobact Dis 34:100405","journal-title":"J Clin Tuberc Other Mycobact Dis"},{"key":"4000_CR12","doi-asserted-by":"publisher","first-page":"S44","DOI":"10.1016\/j.ijtb.2023.07.007","volume":"71","author":"C Vyawahare","year":"2024","unstructured":"Vyawahare C, Mukhida S, Khan S, Gandham NR, Kannuri S, Bhaumik S (2024) Assessment of risk factors associated with drug-resistant tuberculosis in pulmonary tuberculosis patients. Indian J Tuberculosis 71:S44-51","journal-title":"Indian J Tuberculosis"},{"key":"4000_CR13","unstructured":"WHO (2022a) WHO Global TB report for drug resistant TB. Who-Global-TB-Report"},{"key":"4000_CR14","unstructured":"WHO (2022b) TB incidence. WHO-GLOBAL-TB-REPORT. https:\/\/www.who.int\/teams\/global-tuberculosis-programme\/tb-reports\/global-tuberculosis-report-2022\/tb-disease-burden\/2-1-tb-incidence. Accessed Feb\u00a013 2025"},{"key":"4000_CR15","unstructured":"World Health Organisation (2022c) WHO consolidated guidelines on tuberculosis. Module 4: treatment - drug-resistant tuberculosis treatment, 2022 update. https:\/\/www.who.int\/publications\/i\/item\/9789240063129. Accessed Feb\u00a013 2025"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04000-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-025-04000-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04000-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T04:36:43Z","timestamp":1758256603000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-025-04000-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,19]]},"references-count":15,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["4000"],"URL":"https:\/\/doi.org\/10.1007\/s00210-025-04000-6","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"type":"print","value":"0028-1298"},{"type":"electronic","value":"1432-1912"}],"subject":[],"published":{"date-parts":[[2025,3,19]]},"assertion":[{"value":"9 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Ethics Committee of the Institute of Medical Sciences (DCGI registration No. ECR\/526\/Inst\/UP\/2014\/RR-20), approval letter Dean\/2022\/EC\/5055 and follows the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was obtained from each participant in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human ethics and consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}